Michael P. Collins

2.8k total citations
52 papers, 1.7k citations indexed

About

Michael P. Collins is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine and Oncology. According to data from OpenAlex, Michael P. Collins has authored 52 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 10 papers in Pulmonary and Respiratory Medicine and 7 papers in Oncology. Recurrent topics in Michael P. Collins's work include ATP Synthase and ATPases Research (6 papers), Renal cell carcinoma treatment (5 papers) and Mitochondrial Function and Pathology (4 papers). Michael P. Collins is often cited by papers focused on ATP Synthase and ATPases Research (6 papers), Renal cell carcinoma treatment (5 papers) and Mitochondrial Function and Pathology (4 papers). Michael P. Collins collaborates with scholars based in United States, United Kingdom and Israel. Michael P. Collins's co-authors include Michael Forgac, Nigel Paneth, Sabina Signoretti, John M. Lorenz, Bridget K. Buckmeier, James Jetton, J P Kushner, A. H. Filipovich, Michael B. Rothenberg and Joyce Villanueva and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Applied Physics Letters.

In The Last Decade

Michael P. Collins

48 papers receiving 1.7k citations

Peers

Michael P. Collins
Eyas M. Hattab United States
Charles M. Quick United States
Vincent Lemaître United States
G. Zajicek Israel
Bart Smeets Netherlands
Eyas M. Hattab United States
Michael P. Collins
Citations per year, relative to Michael P. Collins Michael P. Collins (= 1×) peers Eyas M. Hattab

Countries citing papers authored by Michael P. Collins

Since Specialization
Citations

This map shows the geographic impact of Michael P. Collins's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael P. Collins with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael P. Collins more than expected).

Fields of papers citing papers by Michael P. Collins

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael P. Collins. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael P. Collins. The network helps show where Michael P. Collins may publish in the future.

Co-authorship network of co-authors of Michael P. Collins

This figure shows the co-authorship network connecting the top 25 collaborators of Michael P. Collins. A scholar is included among the top collaborators of Michael P. Collins based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael P. Collins. Michael P. Collins is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Collins, Michael P., et al.. (2025). Prognostic Implications of SMARCA4 , ARID1A , and Other BAF Mutations in Non‐Small Cell Lung Cancer. Cancer Medicine. 14(24). e71442–e71442.
2.
Llama, Joe, Lily Zhao, John M. Brewer, et al.. (2024). The Lowell Observatory Solar Telescope: a fiber feed into the Extreme Precision Spectrometer. arXiv (Cornell University). 166–166.
4.
Collins, Michael P., et al.. (2022). Isoform a4 of the vacuolar ATPase a subunit promotes 4T1-12B breast cancer cell–dependent tumor growth and metastasis in vivo. Journal of Biological Chemistry. 298(10). 102395–102395. 3 indexed citations
5.
Levine, S. E., C. A. Zuluaga, Michael J. Person, et al.. (2021). Occultation of a Large Star by the Large Plutino (28978) Ixion on 2020 October 13 UTC. The Astronomical Journal. 161(5). 210–210. 5 indexed citations
6.
Collins, Michael P., Laura Stransky, & Michael Forgac. (2020). AKT Ser/Thr kinase increases V-ATPase–dependent lysosomal acidification in response to amino acid starvation in mammalian cells. Journal of Biological Chemistry. 295(28). 9433–9444. 21 indexed citations
7.
Collins, Michael P. & Michael Forgac. (2020). Regulation and function of V-ATPases in physiology and disease. Biochimica et Biophysica Acta (BBA) - Biomembranes. 1862(12). 183341–183341. 121 indexed citations
8.
McGuire, Christina, Michael P. Collins, Ge‐Hong Sun‐Wada, Yoh Wada, & Michael Forgac. (2019). Isoform-specific gene disruptions reveal a role for the V-ATPase subunit a4 isoform in the invasiveness of 4T1-12B breast cancer cells. Journal of Biological Chemistry. 294(29). 11248–11258. 21 indexed citations
9.
Laing, Naomi, Shenghua Wen, David C.H. Yang, et al.. (2013). Inhibition of Platelet-Derived Growth Factor Receptor α by MEDI-575 Reduces Tumor Growth and Stromal Fibroblast Content in a Model of Non-Small Cell Lung Cancer. Molecular Pharmacology. 83(6). 1247–1256. 14 indexed citations
10.
Bhatt, Rupal S., Xiaoen Wang, Liang Zhang, et al.. (2010). Renal Cancer Resistance to Antiangiogenic Therapy Is Delayed by Restoration of Angiostatic Signaling. Molecular Cancer Therapeutics. 9(10). 2793–2802. 48 indexed citations
11.
Cho, Daniel C., David J. Panka, Michael P. Collins, et al.. (2010). The Efficacy of the Novel Dual PI3-Kinase/mTOR Inhibitor NVP-BEZ235 Compared with Rapamycin in Renal Cell Carcinoma. Clinical Cancer Research. 16(14). 3628–3638. 154 indexed citations
12.
Gan, Boyi, Carol S. Lim, Gerald Chu, et al.. (2010). FoxOs Enforce a Progression Checkpoint to Constrain mTORC1-Activated Renal Tumorigenesis. Cancer Cell. 18(5). 472–484. 116 indexed citations
13.
Alba, J. De, Kristof Raemdonck, Michael P. Collins, et al.. (2009). House dust mite induces direct airway inflammationin vivo: implications for future disease therapy?. European Respiratory Journal. 35(6). 1377–1387. 45 indexed citations
14.
Birrell, Mark A., Jorge De Alba, Matthew C. Catley, et al.. (2008). Liver X Receptor Agonists Increase Airway Reactivity in a Model of Asthma via Increasing Airway Smooth Muscle Growth. The Journal of Immunology. 181(6). 4265–4271. 23 indexed citations
15.
Birrell, Mark A., Sissie Wong, Elizabeth Hardaker, et al.. (2006). IκB Kinase-2-Independent and -Dependent Inflammation in Airway Disease Models: Relevance of IKK-2 Inhibition to the Clinic. Molecular Pharmacology. 69(6). 1791–1800. 41 indexed citations
16.
Stein, Miguel, Michael P. Collins, Joyce Villanueva, et al.. (2006). Anti–IL-5 (mepolizumab) therapy for eosinophilic esophagitis. Journal of Allergy and Clinical Immunology. 118(6). 1312–1319. 327 indexed citations
17.
Qiu, Hongqiang, Nigel Paneth, John M. Lorenz, & Michael P. Collins. (2003). Labor and delivery factors in brain damage, disabling cerebral palsy, and neonatal death in low-birth-weight infants. American Journal of Obstetrics and Gynecology. 189(4). 1143–1149. 14 indexed citations
18.
Ramsay, Mary, et al.. (1999). Acute hepatitis B infection in England and Wales: 1985–96. Epidemiology and Infection. 122(1). 125–131. 29 indexed citations
19.
Ramsay, Mary, Nigel Gay, Koye Balogun, & Michael P. Collins. (1998). Control of hepatitis B in the United Kingdom. Vaccine. 16. S52–S55. 35 indexed citations
20.
Collins, Michael P. & Nigel Paneth. (1998). Preeclampsia and cerebral palsy: are they related?. Developmental Medicine & Child Neurology. 40(3). 207–211. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026